看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | -11.7x - -13.0x | -12.4x |
| Selected Fwd P/E Multiple | -7.1x - -7.8x | -7.5x |
| Fair Value | ₩7,179 - ₩7,935 | ₩7,557 |
| Upside | -27.5% - -19.9% | -23.7% |
| Benchmarks | - | Full Ticker |
| SCM Lifescience Co., Ltd. | - | KOSDAQ:A298060 |
| GeneOne Life Science, Inc. | - | KOSE:A011000 |
| Genome & Company | - | KOSDAQ:A314130 |
| HansBiomed Corporation | - | KOSDAQ:A042520 |
| CORESTEMCHEMON Inc. | - | KOSDAQ:A166480 |
| HLB Pep Co., Ltd. | - | KOSDAQ:A196300 |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| A298060 | A011000 | A314130 | A042520 | A166480 | A196300 | |||
| KOSDAQ:A298060 | KOSE:A011000 | KOSDAQ:A314130 | KOSDAQ:A042520 | KOSDAQ:A166480 | KOSDAQ:A196300 | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | NM- | NM- | NM- | NM- | NM- | ||
| 3Y CAGR | NM- | NM- | NM- | NM- | NM- | NM- | ||
| Latest Twelve Months | 48.3% | 37.6% | 57.6% | 59.2% | -48.6% | 25.2% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | -5603.0% | -89.9% | -4057.0% | -17.6% | -48.6% | -75.7% | ||
| Prior Fiscal Year | -3444.2% | -193.4% | -332.0% | -29.5% | -52.5% | -161.8% | ||
| Latest Fiscal Year | -1500.6% | -135.9% | -72.5% | -8.9% | -91.3% | -109.1% | ||
| Latest Twelve Months | -1500.6% | -135.9% | -72.5% | -10.0% | -91.3% | -109.1% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | -3.2x | -7.6x | -4.9x | 25.5x | -7.0x | -33.8x | ||
| Price / LTM Sales | 33.2x | 4.6x | 2.9x | 1.2x | 2.8x | 14.8x | ||
| LTM P/E Ratio | -2.2x | -3.4x | -4.0x | -11.6x | -3.1x | -13.5x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -11.6x | -3.4x | -2.2x | |||||
| Historical LTM P/E Ratio | -33.5x | -15.0x | -11.1x | |||||
| Selected P/E Multiple | -11.7x | -12.4x | -13.0x | |||||
| (x) LTM Net Income | (6,793) | (6,793) | (6,793) | |||||
| (=) Equity Value | 79,819 | 84,020 | 88,221 | |||||
| (/) Shares Outstanding | 9.3 | 9.3 | 9.3 | |||||
| Implied Value Range | 8,588.76 | 9,040.80 | 9,492.84 | |||||
| FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 8,588.76 | 9,040.80 | 9,492.84 | 9,900.00 | ||||
| Upside / (Downside) | -13.2% | -8.7% | -4.1% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | A298060 | A011000 | A314130 | A042520 | A166480 | A196300 | |
| Value of Common Equity | 27,380 | 165,646 | 79,579 | 92,987 | 81,972 | 92,005 | |
| (/) Shares Outstanding | 28.7 | 79.8 | 31.1 | 13.0 | 24.4 | 9.3 | |
| Implied Stock Price | 953.00 | 2,075.00 | 2,560.00 | 7,160.00 | 3,365.00 | 9,900.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 953.00 | 2,075.00 | 2,560.00 | 7,160.00 | 3,365.00 | 9,900.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |